Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis

Abstract Background Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identified adipokine, is increased in diabetic and obese patients. Currently, t...

Full description

Bibliographic Details
Main Authors: Yangxue Yin, Shuangshuang Xie, Qin Xu, Lingyun Liao, Hongqin Chen, Rong Zhou
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-023-01941-w
_version_ 1797451681774960640
author Yangxue Yin
Shuangshuang Xie
Qin Xu
Lingyun Liao
Hongqin Chen
Rong Zhou
author_facet Yangxue Yin
Shuangshuang Xie
Qin Xu
Lingyun Liao
Hongqin Chen
Rong Zhou
author_sort Yangxue Yin
collection DOAJ
description Abstract Background Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identified adipokine, is increased in diabetic and obese patients. Currently, there are several studies describing the relationship between maternal circulating chemerin levels and PE. Therefore, this study aimed to assess their association in pooled samples. Methods Four databases were systematically searched to identify potential studies that reported circulating chemerin levels in PE and normal pregnancy groups. Standardized mean differences (SMDs), 95% confidence intervals (CIs), and 95% prediction intervals (PIs) were calculated using a random-effects meta-analysis. The probability of heterogeneity was also investigated by sensitivity analysis, subgroup analysis, and meta-regression. Results Thirteen studies in 11 articles with a total of 860 PE patients and 1309 women with normal pregnancies met the inclusion criteria. The results of the meta-analysis revealed that circulating chemerin, which levels in PE patients were considerably higher than those in controls (SMD = 1.39, 95% CI: 1.02, 1.77, 95% PI: -0.07, 2.86). Moreover, sensitivity analysis determined that the outcomes of the overall pooled results were not affected after the elimination of any study. Notably, subgroup analysis demonstrated a similar expression pattern irrespective of geographic location, severity, timing of sampling, and sample size. Last, there were no factors that significantly impacted the overall estimate, according to meta-regression. Conclusions This meta-analysis is the first to assess circulating chemerin levels in PE patients. The findings indicate that circulating chemerin levels may be a potential marker to diagnose PE.
first_indexed 2024-03-09T14:58:02Z
format Article
id doaj.art-4e5d6046a9bd426a86cd1b57fc2c05c8
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-03-09T14:58:02Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-4e5d6046a9bd426a86cd1b57fc2c05c82023-11-26T14:05:36ZengBMCLipids in Health and Disease1476-511X2023-10-0122111210.1186/s12944-023-01941-wCirculating chemerin levels in preeclampsia: a systematic review and meta-analysisYangxue Yin0Shuangshuang Xie1Qin Xu2Lingyun Liao3Hongqin Chen4Rong Zhou5Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) of Ministry of EducationDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) of Ministry of EducationDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) of Ministry of EducationDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) of Ministry of EducationDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) of Ministry of EducationDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) of Ministry of EducationAbstract Background Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identified adipokine, is increased in diabetic and obese patients. Currently, there are several studies describing the relationship between maternal circulating chemerin levels and PE. Therefore, this study aimed to assess their association in pooled samples. Methods Four databases were systematically searched to identify potential studies that reported circulating chemerin levels in PE and normal pregnancy groups. Standardized mean differences (SMDs), 95% confidence intervals (CIs), and 95% prediction intervals (PIs) were calculated using a random-effects meta-analysis. The probability of heterogeneity was also investigated by sensitivity analysis, subgroup analysis, and meta-regression. Results Thirteen studies in 11 articles with a total of 860 PE patients and 1309 women with normal pregnancies met the inclusion criteria. The results of the meta-analysis revealed that circulating chemerin, which levels in PE patients were considerably higher than those in controls (SMD = 1.39, 95% CI: 1.02, 1.77, 95% PI: -0.07, 2.86). Moreover, sensitivity analysis determined that the outcomes of the overall pooled results were not affected after the elimination of any study. Notably, subgroup analysis demonstrated a similar expression pattern irrespective of geographic location, severity, timing of sampling, and sample size. Last, there were no factors that significantly impacted the overall estimate, according to meta-regression. Conclusions This meta-analysis is the first to assess circulating chemerin levels in PE patients. The findings indicate that circulating chemerin levels may be a potential marker to diagnose PE.https://doi.org/10.1186/s12944-023-01941-wPreeclampsiaChemerinAdipokineSystematic reviewMeta-analysis
spellingShingle Yangxue Yin
Shuangshuang Xie
Qin Xu
Lingyun Liao
Hongqin Chen
Rong Zhou
Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
Lipids in Health and Disease
Preeclampsia
Chemerin
Adipokine
Systematic review
Meta-analysis
title Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
title_full Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
title_fullStr Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
title_full_unstemmed Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
title_short Circulating chemerin levels in preeclampsia: a systematic review and meta-analysis
title_sort circulating chemerin levels in preeclampsia a systematic review and meta analysis
topic Preeclampsia
Chemerin
Adipokine
Systematic review
Meta-analysis
url https://doi.org/10.1186/s12944-023-01941-w
work_keys_str_mv AT yangxueyin circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis
AT shuangshuangxie circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis
AT qinxu circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis
AT lingyunliao circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis
AT hongqinchen circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis
AT rongzhou circulatingchemerinlevelsinpreeclampsiaasystematicreviewandmetaanalysis